The Intensive Hospital Monitoring for Adverse Drug Reactions of Wuling capsule

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-ONC-13003245

Enrollment

Unknown

Registered

2013-05-20

Start date

2013-06-15

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diseases on the label of Wuling capsule

Interventions

one group:Wuling capsule

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: All the patients that used Wuling capsule in the research centers

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
the incidence of severe adverse drug reaction;	—

Countries

China

Contacts

Public ContactZhong Wang

zhonw@vip.sina.com+86 010 64014411-3308

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026